Education
About Us
Working with TipRanks
Follow Us
Daiichi Co., Ltd. (JP:7643)
:7643
RESEARCH TOOLSreports
Top Page
Daiichi Co., Ltd.
(7643)
77Outperform
Daiichi Co., Ltd. (7643) vs. S&P 500 (SPY)
Market Cap
¥15.99B
Dividend Yield3.43%
Average Volume (3M)4.01K
Price to Earnings (P/E)11.8
Beta (1Y)0.58
Revenue Growth9.00%
EPS Growth8.06%
CountryJP
Employees285
SectorConsumer Defensive
Sector Strength81
IndustryGrocery Stores
Share Statistics
EPS (TTM)119.02
Shares Outstanding11,438,640
10 Day Avg. Volume4,370
30 Day Avg. Volume4,013
Financial Highlights & Ratios
PEG Ratio1.46
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Daiichi Co., Ltd. Business Overview & Revenue Model
Company DescriptionDaiichi Co., Ltd. (7643) is a Japan-based company primarily engaged in the wholesale and retail of medical equipment and supplies. The company operates through various segments, including healthcare, providing a wide range of products such as medical devices, pharmaceuticals, and healthcare consumables. Daiichi Co., Ltd. is committed to enhancing healthcare infrastructure and improving patient care by supplying high-quality medical products and solutions.
How the Company Makes MoneyDaiichi Co., Ltd. generates revenue through the sale of medical equipment and supplies to hospitals, clinics, and other healthcare facilities. The company leverages its extensive distribution network and strong relationships with medical manufacturers to offer a diverse product portfolio. Key revenue streams include direct sales of pharmaceuticals and medical devices, as well as providing value-added services such as logistics and inventory management. Strategic partnerships with healthcare providers and manufacturers also play a vital role in driving sales and expanding market reach.
Daiichi Co., Ltd. Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | ||||
| Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 52.39B | 48.60B | 47.10B | 44.57B | 43.17B | Gross Profit |
| 13.81B | 11.97B | 12.05B | 11.49B | 11.24B | EBIT |
| 1.91B | 1.79B | 1.88B | 1.91B | 1.79B | EBITDA |
| 2.73B | 2.39B | 2.34B | 2.49B | 2.28B | Net Income Common Stockholders |
| 1.42B | 1.23B | 1.16B | 1.29B | 1.17B |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 7.94B | 7.78B | 6.70B | 5.67B | 5.03B | Total Assets |
| 26.20B | 23.48B | 22.28B | 20.90B | 19.51B | Total Debt |
| 753.25M | 1.13B | 1.12B | 1.02B | 805.31M | Net Debt |
| -7.19B | -6.65B | -5.59B | -4.65B | -4.22B | Total Liabilities |
| 9.35B | 7.63B | 7.45B | 7.23B | 6.91B | Stockholders Equity |
| 16.85B | 15.85B | 14.83B | 13.67B | 12.60B |
| Cash Flow | Free Cash Flow | |||
| 1.30B | 1.63B | 1.70B | 575.03M | 2.15B | Operating Cash Flow |
| 2.31B | 1.95B | 1.96B | 2.01B | 2.39B | Investing Cash Flow |
| -1.44B | -244.37M | -290.04M | -1.50B | -256.00M | Financing Cash Flow |
| -810.14M | -615.61M | -622.47M | -383.04M | -695.09M |
Daiichi Co., Ltd. Technical Analysis
Positive
1399.00
Price Trends
1357.67
Positive
1362.36
Positive
1335.07
Positive
Market Momentum
10.33
Negative
63.55
Neutral
61.86
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7643, the sentiment is Positive. The current price of 1399 is above the 20-day moving average (MA) of 1366.50, above the 50-day MA of 1357.67, and above the 200-day MA of 1335.07, indicating a bullish trend. The MACD of 10.33 indicates Negative momentum. The RSI at 63.55 is Neutral, neither overbought nor oversold. The STOCH value of 61.86 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7643.
Daiichi Co., Ltd. Peers Comparison
Overall Rating
UnderperformOutperform
Sector (64)
Financial Indicators
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥15.99B | 11.75 | 3.43% | 9.00% | 8.06% | ||
75 Outperform | ¥38.43B | 14.30 | 2.86% | -1.59% | 57.60% | ||
74 Outperform | ¥567.69B | 21.22 | 10.45% | 1.10% | 17.94% | 18.31% | |
74 Outperform | ¥83.67B | 17.21 | 1.47% | 6.46% | 67.90% | ||
71 Outperform | €384.75B | 20.29 | 10.66% | 1.19% | 17.14% | -14.26% | |
71 Outperform | ¥234.09B | 19.66 | 2.75% | 11.24% | -41.84% | ||
64 Neutral | $8.89B | 14.71 | 5.02% | 174.26% | 3.57% | 3.84% |
* Consumer Defensive Sector Average
Performance Comparison
JP:7643
Daiichi Co., Ltd.
1,399.00
146.20
11.67%
JP:7513
Kojima Co., Ltd.
1,085.00
279.13
34.64%
JP:8185
Chiyoda Co., Ltd.
1,188.00
318.25
36.59%
JP:8273
Izumi Co., Ltd.
3,275.00
-183.22
-5.30%
JP:8279
Yaoko Co., Ltd.
9,449.00
1,147.68
13.83%
JP:7649
Sugi Holdings Co
3,012.00
643.22
27.15%
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.